The Food and Drug Administration (FDA) finally responded to a marijuana-related petition after fully eleven years. After a good long think, the agency finally decided to reject a petition to exempt bulk marijuana and cannabis tinctures from regulated control under a long-standing federal statute, reported Marijuana Moment.

Back in September 2011, Dr. Beverly Mikuriya along with California attorney, William McPike submitted the request for an exemption under the federal Food, Drug and Cosmetic Act (FDAC) that would allow the marketing of bulk cannabis and tinctures without an approved “new drug” application.

Mikuriya and McPike were hoping to be considered under an FDAC grandfather clause that provided exemptions for drugs manufactured before 1938. The petitioners …

Full story available on Benzinga.com